LEQEMBI IQLIK® Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease Life Science Investing
LEQEMBI IQLIK® Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease Life Science Investing
Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic Adenocarcinoma Life Science Investing
Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026 Life Science Investing
Arrowhead Pharmaceuticals to Present New Clinical Data at the European Society of Cardiology Congress Life Science Investing
BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+ Pharmaceutical Investing
Tiziana Life Sciences Announces Poster Presentation on Phase 2a BANYAN Clinical Trial of Intranasal Foralumab at ALS Nexus 2026 Life Science Investing
Monte Rosa Therapeutics Announces First Patient Dosed in MODeFIRe-1, a Phase 2 Study of MRT-2359 in Combination with Apalutamide in Patients with AR Mutation-Positive Metastatic Castration-Resistant Prostate Cancer Life Science Investing
European Commission Expands Role of Gilead's Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across PD-L1 Status Life Science Investing
European Commission Approves DAYBU® as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union Life Science Investing
NurExone Announces Annual General and Special Meeting to Consider Share Consolidation in Support of U.S. Capital Markets Strategy Life Science Investing
